SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-325255
Filing Date
2021-11-10
Accepted
2021-11-10 07:23:15
Documents
16

Document Format Files

Seq Description Document Type Size
1 424B5 d257118d424b5.htm 424B5 534777
2 GRAPHIC g257118g1109042638698.jpg GRAPHIC 4936
3 GRAPHIC g257118g1109042639042.jpg GRAPHIC 33457
4 GRAPHIC g257118g1109042639292.jpg GRAPHIC 21519
5 GRAPHIC g257118g1109042639573.jpg GRAPHIC 27749
6 GRAPHIC g257118g1109042639823.jpg GRAPHIC 11690
7 GRAPHIC g257118g1109042640105.jpg GRAPHIC 21171
8 GRAPHIC g257118g1109042640370.jpg GRAPHIC 4969
9 GRAPHIC g257118g1109042640605.jpg GRAPHIC 9779
10 GRAPHIC g257118g1109042640808.jpg GRAPHIC 5535
11 GRAPHIC g257118g1109042641089.jpg GRAPHIC 23266
12 GRAPHIC g257118g1109042641386.jpg GRAPHIC 25168
13 GRAPHIC g257118g1109042641667.jpg GRAPHIC 15189
14 GRAPHIC g257118g1109042641948.jpg GRAPHIC 24017
15 GRAPHIC g257118g1109042642214.jpg GRAPHIC 5913
16 GRAPHIC g257118g1109044506110.jpg GRAPHIC 5751
  Complete submission text file 0001193125-21-325255.txt   868863
Mailing Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5
Business Address 3009, BOUL. DE LA CONCORDE EAST SUITE 102 LAVAL A8 H7E 2B5 450-686-4555
Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 0331
Type: 424B5 | Act: 33 | File No.: 333-239538 | Film No.: 211394395
SIC: 2834 Pharmaceutical Preparations